CH462178A - Verfahren zur Herstellung von 17a,21-Dihydroxy-20-oxo-4-pregnen-(3,2-c)-pyrazolen - Google Patents

Verfahren zur Herstellung von 17a,21-Dihydroxy-20-oxo-4-pregnen-(3,2-c)-pyrazolen

Info

Publication number
CH462178A
CH462178A CH773463A CH773463A CH462178A CH 462178 A CH462178 A CH 462178A CH 773463 A CH773463 A CH 773463A CH 773463 A CH773463 A CH 773463A CH 462178 A CH462178 A CH 462178A
Authority
CH
Switzerland
Prior art keywords
pregnen
pyrazoles
dihydroxy
oxo
preparation
Prior art date
Application number
CH773463A
Other languages
English (en)
Inventor
Franz Hirschmann Ralph
Allan Patchett Arthur
Rosegay Avery
Joseph Kent Gerald
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH462178A publication Critical patent/CH462178A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/0075—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
CH773463A 1962-06-20 1963-06-20 Verfahren zur Herstellung von 17a,21-Dihydroxy-20-oxo-4-pregnen-(3,2-c)-pyrazolen CH462178A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US203748A US3148183A (en) 1962-06-20 1962-06-20 Delta4 and delta4, 6-17alpha-acyloxy-20-oxo-steroid-[3, 2-c] pyrazoles of the pregnane series
US26230463A 1963-03-04 1963-03-04

Publications (1)

Publication Number Publication Date
CH462178A true CH462178A (de) 1968-09-15

Family

ID=26898869

Family Applications (1)

Application Number Title Priority Date Filing Date
CH773463A CH462178A (de) 1962-06-20 1963-06-20 Verfahren zur Herstellung von 17a,21-Dihydroxy-20-oxo-4-pregnen-(3,2-c)-pyrazolen

Country Status (7)

Country Link
US (1) US3148183A (de)
BE (1) BE633906A (de)
BR (1) BR6349964D0 (de)
CH (1) CH462178A (de)
DE (1) DE1468265A1 (de)
FR (2) FR1552757A (de)
GB (1) GB1044304A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1101117A (en) * 1964-02-01 1968-01-31 Ormonoterapia Richter Spa Steroidal 2ª‡-carbonylhydrazones
US3530117A (en) * 1969-01-09 1970-09-22 Merck & Co Inc Delta**4 and delta**4,6 - 17 - hydroxy - steroidal pyrazoles of the pregnane series
JP2012530140A (ja) 2009-06-16 2012-11-29 メルク・シャープ・アンド・ドーム・コーポレーション グルココルチコイド受容体アゴニストとしての新規［３，２−ｃ］ヘテロアリールステロイド、組成物およびこの使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945852A (en) * 1959-05-20 1960-07-19 Searle & Co 17-oxygenated 9alpha-substituted androstano [3, 2-c] pyrazoles and derivatives

Also Published As

Publication number Publication date
BE633906A (de)
DE1468265A1 (de) 1969-11-20
FR1552757A (de) 1969-01-10
GB1044304A (en) 1966-09-28
BR6349964D0 (pt) 1973-07-03
FR4030M (de) 1966-03-28
US3148183A (en) 1964-09-08

Similar Documents

Publication Publication Date Title
CH453340A (de) Verfahren zur Herstellung von trans-Dimethylolcyclohexan-1,4
CH438343A (de) Verfahren zur Herstellung von 5,6-Dihydro-6-oxo-11H-pyrido (2,3-b) (1,4)-benzodiazepinen
CH462178A (de) Verfahren zur Herstellung von 17a,21-Dihydroxy-20-oxo-4-pregnen-(3,2-c)-pyrazolen
AT242863B (de) Verfahren zur Herstellung von α-Amino-arylmethylpenicillinen
CH430704A (de) Verfahren zur Herstellung von 4,7-Dihalogen-1-methylindan-3-onen
CH426792A (de) Verfahren zur Herstellung von 9(11)-Dehydro-12-desoxy-steroiden
AT235257B (de) Verfahren zur Herstellung von Β, Β'-Dicyandiäthyläther
CH481939A (de) Verfahren zur Herstellung von 4H-Pyrazino-(2,3-d)-(1,3)-oxazin-4-onen
AT250582B (de) Verfahren zur Herstellung von 2-Oxa-3-oxo-steroiden
CH427812A (de) Verfahren zur Herstellung von Oxathiazolinonen
CH442306A (de) Verfahren zur Herstellung von 3,4-Dihydro-benzoxazinonen-(1,3,2)
CH415651A (de) Verfahren zur Herstellung von 3-Aryl-4-halogen-pyridazonen-(6)
CH475985A (de) Verfahren zur Herstellung von substituierten 2-Oxo-tetrahydrochinolinen
AT248445B (de) Verfahren zur Herstellung von neuen 1, 2-Dimehtylhexahydropyridazinen
CH439282A (de) Verfahren zur Herstellung von 11-Keto-5a,9B,10a-19-nor-steroiden
AT241433B (de) Verfahren zur Herstellung von N-Trifluormethyl-N-aryl-aminosulfensäurehalogeniden
AT231451B (de) Verfahren zur Herstellung von 2, 6-Diketo-8-thiapurinen
CH421122A (de) Verfahren zur Herstellung von 1,3,4-Oxdiazolen
CH428769A (de) Verfahren zur Herstellung von 1,8-Dihydroxyanthrachinonyl-5-thioäthern
CH433355A (de) Verfahren zur Herstellung von 2,4-Diamino-6-hydroxymethyl-7,8-dihydro-pteridin
CH431507A (de) Verfahren zur Herstellung von 1,2,3,4-Tetrachlor-9-anthron
CH489484A (de) Verfahren zur Herstellung von 16a- bzw. 16B-Hydroxy-17(20)-pregnen-21-säure-y-lactonen
CH428721A (de) Verfahren zur Herstellung von 4'-Monoacyl-cymarol
AT242149B (de) Verfahren zur Herstellung von 2-Sulfanilamido-5-methoxypyrimidin
AT257064B (de) Verfahren zur Herstellung von 16α-Hydroxysteroiden